Table 1.

Characteristics of the 39 patients developing microscopically proven Pneumocystis pneumonia.

Patient no.	Age (years)	Gender	Underlying condition	30-day outcome	PCR Ct value in BALF sample	Serum BG level (pg/ml)	Time between serum and BALF sampling (days)
Patients with systemic autoimmune or inflammatory disorder
P1§	59	F	Sarcoidosis	Survived	19	3,480	4
P9*,#	69	M	Psoriatic arthritis	Died	27	4,550	1
P15	65	M	Drug-induced interstitial lung disease	Died	26	193	0
P26§	78	M	Rheumatoid arthritis	Died	30	3,885	3
P32	54	M	Crohn’s disease	Survived	26	2,794	2
P34§	63	M	Sarcoidosis	Died	19	2,979	2
P37	69	F	Hashimoto’s thyroiditis	Survived	22	3,510	0
P38	51	F	Focal segmental glomerulosclerosis	Died	20	>5,000	1
P39	69	M	Idiopathic thrombocytopenic purpura	Survived	19.5	610	1
Patients with solid organ transplant
P2	77	M	Kidney transplant	Survived	21	3,952	0
P3	67	F	Kidney transplant	Survived	26.5	1,290	0
P6	65	F	Kidney transplant	Survived	18	1,170	2
P7	69	F	Kidney transplant	Survived	15	3,400	0
P8*,$	68	M	Kidney transplant	Survived	16	3,507	3
P13	58	M	Kidney transplant	Survived	26	4,075	0
P19	67	M	Liver transplant	Survived	18.5	3,410	2
P20	67	M	Kidney transplant	Survived	21	>5,000	1
P21	36	F	Kidney transplant	Survived	19	3,439	1
P22	58	M	Kidney transplant	Survived	23	4,094	0
P24	55	F	Kidney transplant	Survived	18	>5,000	2
P25	62	M	Kidney transplant	Survived	20	2,738	4
P27	33	M	Kidney transplant	Survived	25	2,330	1
P29	61	M	Kidney transplant	Survived	21	>5,000	2
P33	76	F	Kidney transplant	Survived	22	2057	5
P35	69	M	Heart transplant	Survived	24	>5,000	0
Patients with hematological malignancy
P4#,§	58	F	T-cell large granular lymphocyte leukemia	Survived	26.5	2,771	1
P5	64	F	Angioimmunoblastic T-cell lymphoma	Survived	30	1900	2
P10§	70	M	Diffuse large B-cell lymphoma	Died	28	269	1
P11	67	M	Diffuse large B-cell lymphoma	Survived	28.5	211	1
P12#,§	56	M	Burkitt lymphoma	Died	19	1,478	0
P14	58	M	Hodgkin lymphoma	Survived	27.5	117	1
P16	57	M	Mantle cell lymphoma	Survived	26	<31	1
P17	26	M	Hodgkin lymphoma	Survived	26	<31	1
P28	67	M	Hodgkin lymphoma	Died	26	77	10
P30	44	F	Chronic lymphocytic leukemia	Survived	26.5	68	4
P31	78	F	Mixed-phenotype acute leukemia	Survived	34	1,557	0
Patients with solid cancer
P18	62	M	Kidney cancer	Survived	25	40	1
P23	75	M	Squamous cell lung carcinoma	Survived	23	395	0
P36	73	M	Lung adenocarcinoma	Died	18.5	2,890	0

BALF, bronchoalveolar lavage fluid; BG, (1,3)-β-D-glucan; Ct, cycle threshold; F, Female; M, Male.

^*Patients with concurrent invasive candidiasis.

^#Patients with concurrent gram-negative sepsis.

^$Patients receiving intravenous immunoglobulin therapy.

^§Patients receiving methotrexate administration.